Structures by: Westcott S. A.
Total: 35
C17H16O2Se
C17H16O2Se
Catalysis Science & Technology (2018) 8, 14 3617
a=6.7562(4)Å b=7.5182(5)Å c=8.7692(5)Å
α=107.8301(18)° β=98.9760(17)° γ=113.0598(18)°
C13H16O2
C13H16O2
Organic & biomolecular chemistry (2013) 11, 40 7004-7010
a=9.1921(13)Å b=14.0304(18)Å c=9.0659(13)Å
α=90.00° β=114.463(4)° γ=90.00°
C25H27OP
C25H27OP
Dalton transactions (Cambridge, England : 2003) (2020) 49, 16 5092-5099
a=8.317(3)Å b=11.854(4)Å c=11.878(3)Å
α=99.213(7)° β=105.491(8)° γ=107.793(7)°
C39H39BO3P2
C39H39BO3P2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 16 5092-5099
a=12.1297(6)Å b=12.7797(5)Å c=24.5958(11)Å
α=100.177(3)° β=90.169(4)° γ=111.086(3)°
C46H44BO3P2Rh
C46H44BO3P2Rh
Dalton transactions (Cambridge, England : 2003) (2020) 49, 16 5092-5099
a=10.3384(5)Å b=17.0645(8)Å c=11.1586(6)Å
α=90° β=91.508(2)° γ=90°
C37H29BO3P2
C37H29BO3P2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 16 5092-5099
a=10.299(4)Å b=10.930(3)Å c=14.818(5)Å
α=76.664(12)° β=84.069(12)° γ=68.725(12)°
C17H27BN2O2
C17H27BN2O2
New Journal of Chemistry (2003) 27, 10 1419
a=12.5263(6)Å b=12.5263(6)Å c=21.7284(16)Å
α=90.00° β=90.00° γ=90.00°
C96H138B4N16O9
C96H138B4N16O9
New Journal of Chemistry (2003) 27, 10 1419
a=19.5646(9)Å b=16.3302(8)Å c=31.1144(16)Å
α=90.00° β=107.5480(10)° γ=90.00°
C23H33BN2O3
C23H33BN2O3
New Journal of Chemistry (2003) 27, 10 1419
a=9.5447(12)Å b=10.5484(13)Å c=10.9073(13)Å
α=95.987(2)° β=92.320(2)° γ=91.666(2)°
C34H54B2N4O5
C34H54B2N4O5
New Journal of Chemistry (2003) 27, 10 1419
a=10.0250(16)Å b=10.9140(17)Å c=17.365(3)Å
α=106.609(2)° β=105.779(2)° γ=93.244(2)°
C12H17BO2Se
C12H17BO2Se
Chem.Commun. (2014) 50, 8420
a=12.6814(12)Å b=13.1877(13)Å c=16.1788(16)Å
α=90.00° β=90.00° γ=90.00°
C25H35Rh
C25H35Rh
Dalton Transactions (2009) 9 1624-1631
a=7.3306(6)Å b=13.4620(12)Å c=20.7134(19)Å
α=90.00° β=90.00° γ=90.00°
Bis(μ~2~-1,2-bis(Diphenylphosphino)ethyne)- bis(η^5^-indenyl)-di-rodium
C70H54P4Rh2
Dalton Transactions (2009) 9 1624-1631
a=11.6644(2)Å b=13.4814(2)Å c=19.1415(3)Å
α=102.0975(5)° β=92.9700(6)° γ=106.4690(5)°
C45H45P2Rh
C45H45P2Rh
Dalton Transactions (2009) 9 1624-1631
a=11.0600(6)Å b=11.8418(7)Å c=17.1608(10)Å
α=108.854(1)° β=92.464(1)° γ=112.489(1)°
C37H33P2Rh
C37H33P2Rh
Dalton Transactions (2009) 9 1624-1631
a=17.385(4)Å b=10.162(2)Å c=17.492(4)Å
α=90.00° β=103.055(4)° γ=90.00°
C32H36BNO2
C32H36BNO2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 17 4707-4714
a=22.194(4)Å b=7.8827(13)Å c=32.456(6)Å
α=90.00° β=100.937(5)° γ=90.00°
C24H44B2O
C24H44B2O
Dalton transactions (Cambridge, England : 2003) (2011) 40, 17 4707-4714
a=10.170(4)Å b=12.049(4)Å c=19.696(7)Å
α=88.903(9)° β=78.163(7)° γ=86.724(6)°
C27H36BNO
C27H36BNO
Dalton transactions (Cambridge, England : 2003) (2011) 40, 17 4707-4714
a=8.9551(13)Å b=15.564(2)Å c=16.659(3)Å
α=90.00° β=90.00° γ=90.00°
C21H18BNO3
C21H18BNO3
Dalton transactions (Cambridge, England : 2003) (2011) 40, 17 4707-4714
a=16.124(6)Å b=7.653(3)Å c=14.192(5)Å
α=90.00° β=98.931(5)° γ=90.00°
N-[(Benzylcarbamoyl)(phenyl)methyl]-N-[3-(4,4,5,5-tetramethyl-1,3,2- dioxaborolan-2-yl)phenyl]benzamide
C34H35BN2O4
Acta Crystallographica Section E (2006) 62, 6 o2207-o2208
a=11.439(2)Å b=11.648(2)Å c=12.055(2)Å
α=74.377(4)° β=82.844(3)° γ=75.982(3)°
N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-N-(2,4,6- trimethylbenzyl)-p-toluenesulfonamide
C29H36B1N1O4S1
Acta Crystallographica Section E (2002) 58, 11 o1213-o1214
a=12.7798(9)Å b=14.4877(10)Å c=16.5149(12)Å
α=66.858(2)° β=86.916(2)° γ=85.396(2)°
2-Ethyl-3-hydroxy-1-morpholinepyridin-4(1H)-one
C11H16N2O3
Acta Crystallographica Section E (2003) 59, 1 o57-o58
a=8.4379(8)Å b=8.9209(9)Å c=9.3312(12)Å
α=64.020(3)° β=63.198(2)° γ=66.178(2)°
N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-p-toluenesulfonamide
C19H24BNO4S
Acta Crystallographica Section E (2004) 60, 1 o115-o116
a=6.6990(10)Å b=9.4253(15)Å c=16.492(3)Å
α=106.227(2)° β=91.189(2)° γ=105.430(2)°
(Z)-1-Phenyl-3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- yl)phenylamino]but-2-en-1-one
C22H26BNO3
Acta Crystallographica Section E (2005) 61, 10 o3147-o3148
a=5.9593(5)Å b=13.4318(12)Å c=14.4116(13)Å
α=117.2190(10)° β=92.646(2)° γ=98.159(2)°
1,3-Dihydro-1-methoxy-6-methylfuro[3,4-c]pyridinium-7-ol chloride monohydrate
C9H12NO3,H2O,Cl
Acta Crystallographica Section E (2006) 62, 11 o5263-o5264
a=4.1838(5)Å b=17.608(2)Å c=15.181(2)Å
α=90.00° β=94.959(2)° γ=90.00°
Chloridobis(η^5^-cyclopentadienyl)(4-methoxyphenethyl)zirconium(IV)
C19H21ClOZr
Acta Crystallographica Section E (2007) 63, 11 m2790-m2790
a=6.8095(7)Å b=12.3823(12)Å c=20.645(2)Å
α=90.00° β=93.1980(10)° γ=90.00°
Ethyl 6-methyl-4-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-3-yl]- 2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C18H25BN2O4S2
Acta Crystallographica Section E (2008) 64, 5 o929
a=11.9274(17)Å b=13.5021(19)Å c=15.225(2)Å
α=112.172(2)° β=93.531(2)° γ=109.706(2)°
Trans-Dichlorodibenzylaminepalladium(II)
C14H18Cl2N2Pd,2C2H6OS
Acta Crystallographica Section C (2000) 56, 9 1071-1072
a=7.242(2)Å b=16.187(5)Å c=10.596(3)Å
α=90.00° β=109.700(10)° γ=90.00°
C13H19BO2S
C13H19BO2S
The Journal of organic chemistry (2015) 80, 4 2148-2154
a=8.795(2)Å b=8.642(2)Å c=17.912(5)Å
α=90.00° β=95.751(4)° γ=90.00°
C19H20Cl3N2O3Rh,C4H8O
C19H20Cl3N2O3Rh,C4H8O
Inorganic Chemistry (2008) 47, 8727-8735
a=13.268(8)Å b=13.693(8)Å c=14.352(9)Å
α=90.00° β=104.815(9)° γ=90.00°
C21H25N2O2Rh
C21H25N2O2Rh
Inorganic Chemistry (2008) 47, 8727-8735
a=10.8979(13)Å b=11.1449(13)Å c=16.4137(19)Å
α=90.00° β=106.008(2)° γ=90.00°
C19H21N2O2Rh
C19H21N2O2Rh
Inorganic Chemistry (2008) 47, 8727-8735
a=9.442(6)Å b=7.753(5)Å c=24.080(16)Å
α=90.00° β=90.896(11)° γ=90.00°
C26H22BN2O4Rh
C26H22BN2O4Rh
Inorganic Chemistry (2008) 47, 8727-8735
a=11.245(4)Å b=15.187(6)Å c=13.529(5)Å
α=90.00° β=94.561(6)° γ=90.00°
C46H35ClNPPd
C46H35ClNPPd
Organometallics (2014) 33, 19 5209
a=13.5306(7)Å b=18.3786(10)Å c=22.8721(12)Å
α=73.9259(16)° β=73.7859(17)° γ=77.1431(17)°
C25H37IrNP
C25H37IrNP
Organometallics (2006) 25, 25 5965
a=11.0069(8)Å b=9.2904(7)Å c=21.8926(17)Å
α=90.00° β=97.8284(11)° γ=90.00°